IV tranexamic acid reduces postoperative autologous blood retransfusion in THA and TKA
How to Cite
OrthoEvidence. IV tranexamic acid reduces postoperative autologous blood retransfusion in THA and TKA. ACE Report. 2014;3(4):57. Available from: https://myorthoevidene.com/AceReport/Report/6028
Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trialTransfusion. 2014 Jan;54(1):31-41. doi: 10.1111/trf.12224.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
98 patients undergoing TKA or THA were randomized to receive a restrictive blood transfusion program either with an intraoperative intravenous 1.0 g dose of tranexamic acid (TXA) and a repeated dose 3 hours later or a placebo. Analysis revealed that a lower proportion of TXA patients required reinfusion of postoperatively collected autologous blood, in addition to a reduction in mean total extern...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE